Product Code: CHAT
TABLE OF CONTENTS
List Of Contents And Tables
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 2 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2016-2021
Table 4 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 5 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 6 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
Table 8 Distribution of Consumer Health by Format: % Value 2016-2021
Table 9 Distribution of Consumer Health by Format and Category: % Value 2021
Table 10 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2020-2021
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources
ANALGESICS IN AUSTRIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Demand boosted by return to more normal routines
Pandemic adds to reasons to self-medicate
Bayer at sales summit
PROSPECTS AND OPPORTUNITIES
Positive outlook though slight deceleration predicted
Internationals likely to keep leading sales
Investment in production may be seen if supply problems linger
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2016-2021
Table 13 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 14 NBO Company Shares of Analgesics: % Value 2017-2021
Table 15 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 16 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN AUSTRIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Signs of recovery, but sales still sluggish
Leading players offer variety and innovation
Emphasis on treating COVID-19 symptoms influences various categories
PROSPECTS AND OPPORTUNITIES
Overall sales to fully recover in 2022
Rise in respiratory problems to fuel demand further
Alternative remedies could hinder category
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026
DIGESTIVE REMEDIES IN AUSTRIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Return to foodservice combined with pandemic strain takes toll on digestive systems
Hectic lifestyles keep digestive remedies in demand for many
Sanofi-Aventis remains leader despite losing slight share
PROSPECTS AND OPPORTUNITIES
Modern ways of living expected to keep demand steady
Internationals likely to keep driving sales
Producers to invest more in innovation and range
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2016-2021
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2016-2021
Table 26 NBO Company Shares of Digestive Remedies: % Value 2017-2021
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2018-2021
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2021-2026
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2021-2026
DERMATOLOGICALS IN AUSTRIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Overall sales avoid decline but still underperform
Internationals lead crowded landscape
Child-related products take a hit from home seclusion
PROSPECTS AND OPPORTUNITIES
Higher need for dermatologicals on the horizon
Uphill battle for paediatric products
Regaine set to ride out blip
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2016-2021
Table 31 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 32 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 33 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2018-2021
Table 35 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
NRT SMOKING CESSATION AIDS IN AUSTRIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Sales still limited by consumer mistrust and popularity of alternatives
Category unable to capitalise on pandemic push to quit smoking
Duopoly shapes the competitive landscape
PROSPECTS AND OPPORTUNITIES
Uptick in sales performance expected
Competition unlikely to strengthen as category will remain relatively niche
Discretion likely to play significant role in product choice
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2016-2021
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2017-2021
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2018-2021
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2021-2026
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2021-2026
SLEEP AIDS IN AUSTRIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Growth less steep, but health crisis still boosting sales
Natural remedies dominate sleep aids
Consumers rest easy after buying the leading names
PROSPECTS AND OPPORTUNITIES
Consumers unlikely to hit the snooze button on sleep aids
New brand Easysleep is catching the eye
Good sales performance of sleep aids could see competition heat up
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2016-2021
Table 45 Sales of Sleep Aids: % Value Growth 2016-2021
Table 46 NBO Company Shares of Sleep Aids: % Value 2017-2021
Table 47 LBN Brand Shares of Sleep Aids: % Value 2018-2021
Table 48 Forecast Sales of Sleep Aids: Value 2021-2026
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2021-2026
EYE CARE IN AUSTRIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Standard eye care bounces back but allergy ranges continue to decline
Digitalisation and ageing population provide solid platform for demand
Bausch & Lomb stays at sales summit
PROSPECTS AND OPPORTUNITIES
Eye care poised for healthy gains
International brands predicted to remain the go-to products
Greater product sophistication expected
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2016-2021
Table 51 Sales of Eye Care by Category: % Value Growth 2016-2021
Table 52 NBO Company Shares of Eye Care: % Value 2017-2021
Table 53 LBN Brand Shares of Eye Care: % Value 2018-2021
Table 54 Forecast Sales of Eye Care by Category: Value 2021-2026
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2021-2026
WOUND CARE IN AUSTRIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Quick recovery for wound care sales
Private label on the rise
High brand loyalty reflected in the strong positions of top three players
PROSPECTS AND OPPORTUNITIES
Overall category set to make further small gains
First aid kits poised for marginal volume sales decline
Value sales growth potential appears limited
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2016-2021
Table 57 Sales of Wound Care by Category: % Value Growth 2016-2021
Table 58 NBO Company Shares of Wound Care: % Value 2017-2021
Table 59 LBN Brand Shares of Wound Care: % Value 2018-2021
Table 60 Forecast Sales of Wound Care by Category: Value 2021-2026
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2021-2026
VITAMINS IN AUSTRIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Further volume sales gains recorded as consumers prioritise immune health
Consumers cover all bases with multivitamins
Mental and physical toll of pandemic being felt
PROSPECTS AND OPPORTUNITIES
Performance not likely to be as effervescent in forecast period
Saturation likely to invigorate innovation and NPD
Sanova is a local player to watch
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2016-2021
Table 63 Sales of Vitamins by Category: % Value Growth 2016-2021
Table 64 Sales of Multivitamins by Positioning: % Value 2016-2021
Table 65 NBO Company Shares of Vitamins: % Value 2017-2021
Table 66 LBN Brand Shares of Vitamins: % Value 2018-2021
Table 67 Forecast Sales of Vitamins by Category: Value 2021-2026
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2021-2026
DIETARY SUPPLEMENTS IN AUSTRIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Dietary supplements a popular choice for fortifying the immune system
Performances of leading players begin to stabilise in 2021
Plant-based ranges showing promise
PROSPECTS AND OPPORTUNITIES
Preventative trend to remain strong, supporting robust sales growth
Dietary supplements unlikely to fit into everyone's health drive
Consolidation expected from leading companies
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2016-2021
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2016-2021
Table 71 Sales of Dietary Supplements by Positioning: % Value 2016-2021
Table 72 NBO Company Shares of Dietary Supplements: % Value 2017-2021
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2018-2021
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2021-2026
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2021-2026
WEIGHT MANAGEMENT AND WELLBEING IN AUSTRIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Demand still diminished by financial and movement restrictions
Herbalife is the runaway leader
The comprehensive approach appeals the most
PROSPECTS AND OPPORTUNITIES
Category set to thrive as health takes centre stage
Wish to look good is another driver for sales growth
Price's influence on consumers set to deepen
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2016-2021
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2016-2021
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2017-2021
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2018-2021
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2021-2026
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2021-2026
SPORTS NUTRITION IN AUSTRIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Easing of pandemic restrictions motivates consumers to exercise more
Availability is expanding, boosting sales further
Producers pay more attention to mainstream consumers
PROSPECTS AND OPPORTUNITIES
Sports nutrition to go from strength to strength
Social media marketing to play pivotal role
Convenient consumption to be a big attraction
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2016-2021
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2016-2021
Table 84 NBO Company Shares of Sports Nutrition: % Value 2017-2021
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2018-2021
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2021-2026
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2021-2026
HERBAL/TRADITIONAL PRODUCTS IN AUSTRIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Mixed results owing to pandemic influence
Bad PR for Iberogast
More consumers favouring standard remedies amid COVID-19
PROSPECTS AND OPPORTUNITIES
Sales to pick up and restrengthen as consumer concerns ease
Prevention trend may both hinder and boost category
Low barriers to entry and high growth potential will fragment sales further
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2016-2021
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2016-2021
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2017-2021
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2018-2021
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2021-2026
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2021-2026
PAEDIATRIC CONSUMER HEALTH IN AUSTRIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Two categories play key role in overall gains in 2021
Local player Apomedica has commanding lead
Sales base is still niche in Austria
PROSPECTS AND OPPORTUNITIES
Demand set to dwindle as infant population decreases
Paediatric health products likely to remain relatively unpopular
Companies may have to be proactive to unlock greater category potential
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2016-2021
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2016-2021
Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2021
Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2017-2021
Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2018-2021
Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2021-2026
Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2021-2026
